Cargando…

Serum Adiponectin Level and Clinical, Metabolic, and Hormonal Markers in Patients with Polycystic Ovary Syndrome

BACKGROUND: To investigate the relationship between adiponectin, metabolic and hor- monal parameters, and insulin resistance in patients with non-treated polycystic ovary syndrome. MATERIALS AND METHODS: In this cross-sectional observational study, 81 patients admitted to out-patient clinic with com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yildiz, Yunus, Ozaksit, Gülnur, Serdar Unlu, Bekir, Ozgu, Emre, Energin, Hasan, Kaba, Metin, Ugur, Mustafa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Royan Institute 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901186/ https://www.ncbi.nlm.nih.gov/pubmed/24520503

Ejemplares similares

Serum Vitamin D Levels in Fertile and Infertile Women with Polycystic Ovary Syndrome
por: Kokanalı, Demet, et al.
Publicado: (2019)

Adiponectin in Women with Polycystic Ovary Syndrome
por: Shin, Hyun-Young, et al.
Publicado: (2011)

Heart rate variability and heart rate turbulence in patients with polycystic ovary syndrome
por: Özkeçeci, Gülay, et al.
Publicado: (2016)

Assessment of Anti-Müllerian Hormone Level in Management of Adolescents with Polycystic Ovary Syndrome
por: Dursun, Fatma, et al.
Publicado: (2016)

Relationship between Serum Levels of Anti-Mullerian Hormone, Adiponectin and Oxidative Stress Markers in Patients with Polycystic Ovary Syndrome
por: Kohzadi, Mozhgan, et al.
Publicado: (2020)

Serum adiponectin in Indian women with polycystic ovary syndrome
por: Rajendra, Aishwarya, et al.
Publicado: (2023)

Serum Anti-Müllerian Hormone in Polycystic Ovary Syndrome and its Relationship with Insulin Resistance, Lipid Profile and Adiponectin
por: Jun, Thien Jun, et al.
Publicado: (2020)

Ovarian HMW adiponectin is associated with folliculogenesis in women with polycystic ovary syndrome
por: Tao, Tao, et al.
Publicado: (2013)

Association of adiponectin levels with polycystic ovary syndrome among Indian women
por: Patil, Sudha, et al.
Publicado: (2022)

Variation in Clinical Presentation, Metabolic Profile, Hormonal Parameters and Inflammatory Markers in Polycystic Ovary Syndrome Women with and without Polycystic Ovary Morphology Appearance
por: Jena, Sweekruti, et al.
Publicado: (2023)

Adiponectin and Its Receptors in the Ovary: Further Evidence for a Link between Obesity and Hyperandrogenism in Polycystic Ovary Syndrome
por: Comim, Fabio V., et al.
Publicado: (2013)

The assessment of thyroid autoantibody levels in euthyroid patients with polycystic ovary syndrome
por: Hepşen, Sema, et al.
Publicado: (2018)

An Update on Contraception in Polycystic Ovary Syndrome
por: Oguz, Seda Hanife, et al.
Publicado: (2021)

The Polycystic Ovary Syndrome: An update on metabolic and hormonal mechanisms
por: Dumitrescu, R, et al.
Publicado: (2015)

Polycystic ovary syndrome and circulating inflammatory markers
por: Zafari Zangeneh, Farideh, et al.
Publicado: (2017)

Inflammatory Markers in Women with Polycystic Ovary Syndrome
por: Rudnicka, E., et al.
Publicado: (2020)

Effect of Vitamin D(3) on Chemerin and Adiponectin Levels in Uterus of Polycystic Ovary Syndrome Rats
por: Pich, Karolina, et al.
Publicado: (2023)

The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of PPAR-γ
por: Unluturk, Ugur, et al.
Publicado: (2007)

Polycystic ovary syndrome and the risk of obstructive sleep apnea: a meta-analysis and review of the literature
por: Helvaci, Nafiye, et al.
Publicado: (2017)

Levels of Neopterin and other Inflammatory Markers in Obese and Non-Obese Patients with Polycystic Ovary Syndrome
por: Agacayak, Elif, et al.
Publicado: (2015)

Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome
por: Dewailly, Didier, et al.
Publicado: (2020)

The role of gonadotropin‐releasing hormone neurons in polycystic ovary syndrome
por: McCartney, Christopher R., et al.
Publicado: (2022)

Correlation between serum adiponectin and clinical characteristics, biochemical parameters in Indian women with polycystic ovary syndrome
por: Ramanand, Sunita J., et al.
Publicado: (2014)

Adiponectin/(FBG × FIns) as a predictor of insulin sensitivity and metabolic syndrome in patients with polycystic ovary syndrome
por: Xu, Xiaohui, et al.
Publicado: (2016)

Role of osteocalcin, tumor necrosis factor-alpha and adiponectin in polycystic ovary syndrome patients with insulin resistance
por: Erkan, Gönül, et al.
Publicado: (2017)

New markers of insulin resistance in polycystic ovary syndrome
por: Polak, K., et al.
Publicado: (2016)

Does mid-luteal progesterone predict pregnancy in intrauterine insemination cycles following sequential clomiphene citrate and gonadotropin treatment?
por: Çinar, Mehmet, et al.
Publicado: (2023)

Association of the genetic variants of luteinizing hormone, luteinizing hormone receptor and polycystic ovary syndrome
por: Liu, Nana, et al.
Publicado: (2012)

Is anti-Mullerian hormone a good diagnostic marker for adolescent and young adult patients with Polycystic ovary syndrome?
por: Tokmak, Aytekin, et al.
Publicado: (2015)

The relationship between Polycystic ovary syndrome and vitamin D levels
por: Yılmaz, Setenay Arzu, et al.
Publicado: (2015)

Adiponectin Gene Polymorphism (rs17300539) Has No Influence on the Occurrence of Metabolic Syndrome in Women with Polycystic Ovary Syndrome
por: Nowak, Izabela, et al.
Publicado: (2021)

Steroid hormone profiling in obese and nonobese women with polycystic ovary syndrome
por: Deng, Yuying, et al.
Publicado: (2017)

Association between the prevalence of hyperuricemia and reproductive hormones in polycystic ovary syndrome
por: Mu, Liangshan, et al.
Publicado: (2018)

The Relevant Hormonal Levels and Diagnostic Features of Polycystic Ovary Syndrome in Adolescents
por: Khashchenko, Elena, et al.
Publicado: (2020)

Effects of Ketogenic Diet on Reproductive Hormones in Women With Polycystic Ovary Syndrome
por: Khalid, Karniza, et al.
Publicado: (2023)

Study of early atherosclerotic markers in women with polycystic ovary syndrome
por: Karoli, Ritu, et al.
Publicado: (2012)

Markers of insulin resistance in Polycystic ovary syndrome women: An update
por: Amisi, Chantal Anifa
Publicado: (2022)

Hashimoto’s thyroiditis worsens ovaries in polycystic ovary syndrome patients compared to Anti-Müllerian hormone levels
por: Serin, Aliye Nigar, et al.
Publicado: (2021)

Cutaneous manifestation of polycystic ovary syndrome
por: Abusailik, Mohammad A., et al.
Publicado: (2021)

Anti-Műllerian hormone – a prognostic marker for metformin therapy efficiency in the treatment of women with infertility and polycystic ovary syndrome
por: Neagu, M, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_f2cd0amcg5ol33r4hn08s3h6t4